About Nu Vision
Nu Vision is a company based in Nottingham (United Kingdom) founded in 2015. Nu Vision has raised $13.39 million across 6 funding rounds from investors including Mercia, Newable and The University of Nottingham. Nu Vision offers products and services including Omnigen and OmniLenz. Nu Vision operates in a competitive market with competitors including Imbed Biosciences, MiMedx Group, Cresilon, Kane Biotech and BioTissue, among others.
- Headquarter Nottingham, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nuvision Biotherapies Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.39 M (USD)
in 6 rounds
-
Latest Funding Round
$6.57 M (USD), Series B
Feb 05, 2026
-
Investors
Mercia
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nu Vision
Nu Vision offers a comprehensive portfolio of products and services, including Omnigen and OmniLenz.
Natural amniotic membrane dressing for ocular wound healing and recovery.
Bespoke lens for rapid, surgery-free ocular care and treatment.
People of Nu Vision
Unlock access to complete
Unlock access to complete
Funding Insights of Nu Vision
Nu Vision has successfully raised a total of $13.39M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $6.57 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nu Vision
Nu Vision has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Mercia, Newable and The University of Nottingham.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment funding is provided to support Midlands SMEs growth.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Life Science focused startup accelerator and incubator
|
Locked | Locked | Locked |
Investor details for Nu Vision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nu Vision
Investment portfolio details for Nu Vision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nu Vision
Detailed financials for Nu Vision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nu Vision Comparisons
Peer comparison for Nu Vision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nu Vision
Nu Vision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, MiMedx Group, Cresilon, Kane Biotech and BioTissue, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanotech-based wound care products are developed and provided.
|
|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Developer of hemostatic products for wound care
|
|
| Locked | Locked | Locked |
Therapeutic solutions for biofilm prevention and removal are developed.
|
|
| Locked | Locked | Locked |
Regenerative biologic therapies for eye care are developed and provided.
|
|
| Locked | Locked | Locked |
Biomaterials and devices for internal wound healing are developed.
|
Detailed competitors of Nu Vision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nu Vision
Complete news archive for Nu Vision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nu Vision
Nu Vision was founded in 2015.
Nu Vision is headquartered in Nottingham, United Kingdom.
Nu Vision is a funded company, having raised a total of $13.39M across 6 funding rounds to date.
NuVision was founded in 2015 in Nottingham, United Kingdom, within the biotechnology sector focused on ophthalmic care. Regenerative wound dressings are developed for the eyes surface, including Omnigen, a dry preserved biological matrix derived from human amniotic membrane used in wound care. An OmniLenz bandage contact lens is also provided for suture-free transplantation. Operations center on biological matrix preservation and application in eye regeneration.
Nu Vision's top competitors include Imbed Biosciences, MiMedx Group and Cresilon.
Nu Vision offers Omnigen and OmniLenz.
Nu Vision has 8 investors. Key investors include Mercia, Newable, The University of Nottingham, BioCity, and Midlands Engine Investment Fund.